Importantly, ER and HER2 were not strongly correlated with signalling effectors, suggesting that mTOR and/or MAPK activation are to some extent independent of the ER or HER2 status of individual cancer cells (Fig. 2d). This evidence concerns the gene ERBB2 and cancer.